N/A N=90 Respiration Rate V2.0 in a Hospital Setting
Respiratory Rate
Primary: Mean Error (ME) +/- 1 Breath Per Minute, RR Sensor — -0.82 BrPM (breaths per minute)
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=22 Non-invasive Ventilation System in Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Disease, Chronic Obstructive · Airflow Obstruction, Chronic · Chronic Obstructive Airway Disease
Primary: Device Tidal Volume — 180 mL
N/A N=30 Respiration Rate V2.0 in Healthy Volunteers
Focus of the Study is Measuring Respiratory Rate
Primary: Mean Error (ME) +/- 1 Breath Per Minute, RR Sensor — -0.05 BrPM
N/A N=50 Extracorporeal Lung Assist to Avoid Intubation in Patients Failing Noninvasive Ventilation for Hypercapnic ARF
Hypercapnia · Respiratory Insufficiency
Primary: Number of Patients With Need for Intubation for Invasive Mechanical Ventilation — 11; 25 Participants
N/A N=30 In-home Evaluation of a Noninvasive Open Ventilation System in Patients With Severe Respiratory Insufficiency
Pulmonary Disease, Chronic Obstructive · Airflow Obstruction, Chronic · Chronic Obstructive Airway Disease
Primary: Activity Endurance Time — 7.24; 13.38 minutes — p=<0.05
N/A N=6 Rebreathing of Carbon Dioxide With a Device Used for Giving Inhalational Anaesthesia
Anesthetic Ventilatory Requirements
Primary: Airway Dead Space With Devices for Heat and Moisture Exchange of Respiratory Gas. — 136 mL
N/A N=41 Respiration Validation for CPM Device
Cardiopulmonary Disease
Primary: Accuracy of CPM System Calculated RR Versus Reference Device Via Percent of Error Accuracy of Respiration Rate — 99.1; 98.5 Percent
N/A N=29 Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease
Amyotrophic Lateral Sclerosis (ALS) · Neuromuscular Diseases
Primary: Percent Change in Maximal Inspiratory Pressure (MIP) — 0.3; -3.1; -4.8; -5.0 percentage change in MIP from baseline
Phase 2 N=6 Extracorporeal Membrane Oxygenation (ECMO) in Non-intubated Patients With Acute Respiratory Distress Syndrome (ARDS)
ARDS
Primary: Number of Participants That Did Not Require Endotrachael Intubation — 3 participants
N/A N=34 Study of Nasal Ventilation In Preterm Infants To Decrease Time on The Respirator
Bronchopulmonary Dysplasia
Primary: Number of Days Being Intubated — 12.4; 6.2 days
N/A N=6 Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)
Healthy Adult Volunteers
Primary: Change in End-expiratory Lung Volume — -144; 103 mL
N/A N=30 Ability of Caregivers to Provide Ventilation With the SAVe Resuscitator in a Model
Pre-hospital Ventilation
Primary: Tidal Volume — 341.8; 27.5; 604.1 milliliters (mL) — p=<0.0001
Phase 2 N=30 High Flow Oxygen and Bilevel Airway Pressure for Persistent Dyspnea in Patients With Advanced Cancer
Advanced Cancers
Primary: Number of Participants Completing Study Intervention — 7; 10; 3; 5 Participants
N/A N=63 Neonatal Resuscitation - Sustained Inflations
Premature Birth
Primary: Expiratory Tidal Volume — 153; 194 ml/kg/min
N/A N=15 Effects of the Breathe Technologies Ventilation System in Subjects With Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease
Primary: Exercise Duration for Constant Work Rate Exercise Tests Under 4 Test Conditions — 6.3; 17.5; 11.4; 5.6 minutes — p=<0.05
N/A N=78 AMBU Bag Manual Ventilation vs. Transport Ventilator Mechanical Ventilation for Transport
Oxygenation · Manual Ventilation · Mechanical Ventilation
Primary: The % Change in Mean Artery Blood Pressure — -3.73; 13 % change in mean artery pressure
N/A N=15 Acute Effect of Ventilatory Support During Exercise in Spinal Cord Injury
Spinal Cord Injury
Primary: Change in Peak Aerobic Capacity During FES-row Testing — 1.83; 1.82 L/min
N/A N=25 Servo-Ventilation In-lab PSG Evaluation
Sleep Apnea Syndromes
Primary: Average Apnea Hypopnea Index Among Different Polysomnography Devices. — 18.4; 25.4; 24.1; 19.2 events per hour
N/A N=11 Ventilatory Support to Improve Exercise Training in High Level Spinal Cord Injury
Spinal Cord Injury
Primary: Change in Baseline Aerobic Capacity After 3 Months of FES-row Training. — 0.21; 0.08 L/min
N/A N=751 Protocolized Post-Extubation Respiratory Support Study
Mechanical Ventilation Complication · Acute Respiratory Failure · Intubation Complication
Primary: Reintubation — 57; 52 Participants
Phase 2 N=31 Capnometry-Assisted Breathing Training for COPD
Chronic Obstructive Pulmonary Disease
Primary: Number of Participants With Adherence to Home Breathing Exercises — 10; 5 Participants
N/A N=35 Oxygenation Via Frova Bougie and Ambu Bag
Failed or Difficult Intubation
Primary: Tidal Volume (ml) — 954.8; 554.4; 893.5; 542.9 tidal volume (ml)
N/A N=40 Non-invasive Tidal Volume Monitoring Using the Linshom Respiratory Monitoring Device
Pulmonary Ventilation · Capnography
Primary: Tidal Volume of Each Breath Was Measured Using the Same Breathing Mask CPAP Apparatus Combined With Respiratory Monitoring Device Allowing for Simultaneous Recording…
N/A N=27 INVSENSOR00032 and INVSENSOR00033 Respiration Rate Clinical Performance Study
Healthy
Primary: RRp Arms of Sensor Accuracy — 2.1 respiration per minute (RPM)
N/A N=20 GO2 PEEP Study: Bidirectional Oxygenation Valve in Postoperative Atelectasis
Postoperative Atelectasis
Primary: Partial Pressure of Oxygen (PaO2 Level) — 95.4; 83.5; 92.1; 85.4 mmHg
N/A N=39 A Comparison of Different Ventilation Strategies in Infants Using the PLMA™
Ventilation
Primary: Mean Values of End-tidal Carbon Dioxide and Tidal Volume Compared Between the Spontaneous Ventilation and Pressure Support Ventilation Groups. — 4.5; 7; 51.8; 49 cc/kg
N/A N=29 Electric Blower Based Ventilator Used During Procedural Sedation
Apnea During Procedural Sedation
Primary: Percentage of Time the Patient Will Experience Apnea — 11 % time in apnea of total study duration
N/A N=28 ALS and Airway Clearance (ALSAC) Therapy
Amyotrophic Lateral Sclerosis · Respiratory Muscle Weakness
Primary: Respiratory Complications Severity — 8.33; 9.0; 7.8 score on a scale
N/A N=24 Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Emphysema · Chronic Obstructive Pulmonary Disease (COPD) · Cystic Fibrosis
Primary: 30 Day Mortality and Graft Survival — 0; 22; 0; 2 Participants
N/A N=62 Mask Ventilation With Different Face Masks During Neonatal Resuscitation
Respiration; Insufficient or Poor, Newborn
Primary: Difference in Percentage of Leak — 35; 30 % (percentage of mass leak)